VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report)’s stock price was down 9.1% on Friday . The company traded as low as C$0.20 and last traded at C$0.20. Approximately 104,000 shares changed hands during mid-day trading, an increase of 6% from the average daily volume of 97,875 shares. The stock had previously closed at C$0.22.
VentriPoint Diagnostics Stock Down 9.1 %
The company’s 50 day simple moving average is C$0.21 and its 200-day simple moving average is C$0.24. The firm has a market cap of C$31.36 million, a P/E ratio of -6.67 and a beta of 0.43. The company has a current ratio of 1.17, a quick ratio of 6.67 and a debt-to-equity ratio of 217.41.
VentriPoint Diagnostics Company Profile
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model that generates accurate heart volumetric measurements.
Featured Articles
- Five stocks we like better than VentriPoint Diagnostics
- P/E Ratio Calculation: How to Assess Stocks
- 3M Surprises and Rebound Accelerates: It Isn’t Too Late To Get In
- Investing in Travel Stocks Benefits
- Skechers Stock Shows Strength Among Consumer Discretionary Sector
- 3 Warren Buffett Stocks to Buy Now
- Tech Stocks Tumble, These Stocks Present Buying Opportunity
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
